Selective activation of group-II metabotropic glutamate receptors is protective against excitotoxic neuronal death.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  European Journal of Pharmacology

• Publication date

  1998-09-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0014-2999(98)00551-2PMID 9774259
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuroprotective activity of N-acetylaspartylglutamate in cultured cortical cells.

  1998cited by this paper
• In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats.

  1997cited by this paper
• The Neuroprotective Activity of Group-II Metabotropic Glutamate Receptors Requires New Protein Synthesis and Involves a Glial–Neuronal Signaling

  1997cited by this paper
• LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors.

  1997cited by this paper
• (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors.

  1996cited by this paper
• DCG‐IV Selectively Attenuates Rapidly Triggered NMDA‐induced Neurotoxicity in Cortical Neurons

  1996cited by this paper
• Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders?

  1996cited by this paper
• The novel metabotropic glutamate receptor agonist 2R,4R-APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: evidence for a synergistic interaction between group 1 and group 2 receptors.

  1996cited by this paper
• Activation of Class II or III Metabotropic Glutamate Receptors Protects Cultured Cortical Neurons Against Excitotoxic Degeneration

  1995cited by this paper
• Phenylglycine derivatives discriminate between mGluR1- and mGluR5-mediated responses.

  1995cited by this paper
• Metabotropic glutamate receptors negatively coupled to adenylate cyclase inhibit N-methyl-D-aspartate receptor activity and prevent neurotoxicity in mesencephalic neurons in vitro.

  1995cited by this paper
• Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide.

  1995cited by this paper
• The inhibitory mGluR agonist, S-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death.

  1995cited by this paper
• The metabotropic glutamate receptors: structure and functions.

  1995cited by this paper
• Neuron damage induced by some potent kainoids and neuroprotective action of new agonists for metabotropic glutamate receptors.

  1994cited by this paper
• Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death.

  1994cited by this paper
• 4 – Cytotoxicity in Murine Neocortical Cell Culture

  1993cited by this paper
• A novel metabotropic glutamate receptor agonist: marked depression of monosynaptic excitation in the newborn rat isolated spinal cord

  1993cited by this paper
• Role of a metabotropic glutamate receptor in synaptic modulation in the accessory olfactory bulb

  1993cited by this paper
• Molecular diversity of glutamate receptors and implications for brain function.

  1992cited by this paper
• Agonist analysis of 2‐(carboxycyclopropyl)glycine isomers for cloned metabotropic glutamate receptor subtypes expressed in Chinese hamster ovary cells

  1992cited by this paper

• Metabotropic Glutamate Receptor 2/3 Activation Improves Motor Performance and Reduces Pathology in Heterozygous zQ175 Huntington Disease Mice

  2021cites this paper
• Activation of Group II Metabotropic Glutamate Receptors Increases Proliferation but does not Influence Neuronal Differentiation of a Human Neural Stem Cell Line

  2018cites this paper
• 6.06 – Excitotoxicity☆

  2018cites this paper
• Co-Activation of Metabotropic Glutamate Receptor 3 and Beta-Adrenergic Receptors Modulates Cyclic-AMP and Long-Term Potentiation, and Disrupts Memory Reconsolidation

  2017cites this paper
• University of Southern Denmark Activation of Group II Metabotropic Glutamate Receptors Increases Proliferation but does not Influence Neuronal Differentiation of a Human Neural Stem Cell Line Dindler,

  2017cites this paper
• Syddansk Universitet Activation of Group II Metabotropic Glutamate Receptors Increases Proliferation but does not Influence Neuronal Differentiation of a Human Neural Stem Cell Line

  2017cites this paper
• Metabotropic glutamate receptor 5 in Down's syndrome hippocampus during development: increased expression in astrocytes.

  2014cites this paper
• Synergistic association of PI4KA and GRM3 genetic polymorphisms with poor antipsychotic response in south Indian schizophrenia patients with low severity of illness

  2014cites this paper
• Metabotropic glutamate receptors in neurodegeneration/neuroprotection: still a hot topic?

  2012cites this paper
• The Protective Effects of Pre-Treatment with Glutamate Metabotropic Receptor Agonists on the Development of Parkinsonian Movements

  2011cites this paper
• Neuron-Astroglial Interactions in Cell Fate Commitment in the Central Nervous System

  2010cites this paper
• AMPA and metabotropic excitoxicity explain subplate neuron vulnerability.

  2010cites this paper
• Striatal ablation of GABAergic neurons prevents the in vivo neuroprotective effect of DCG-IV against the MPP+-induced neurotoxicity on dopaminergic nerve terminals.

  2010cites this paper
• The neuroprotectant properties of glutamate antagonists and antiglutamatergic drugs

  2009cites this paper
• Posttreatment with group II metabotropic glutamate receptor agonist 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate is only weakly effective on seizures in immature rats.

  2009cites this paper
• Molecular alterations in epilepsy-associated malformations of cortical development

  2009cites this paper
• ELLULAR LOCALIZATION OF METABOTROPIC GLUTAMATE ECEPTORS IN CORTICAL TUBERS AND SUBEPENDYMAL GIANT ELL TUMORS OF TUBEROUS SCLEROSIS COMPLEX

  2008cites this paper
• Expression of a GRM3 Splice Variant is Increased in the Dorsolateral Prefrontal Cortex of Individuals Carrying a Schizophrenia Risk SNP

  2008cites this paper
• Cellular localization of metabotropic glutamate receptors in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex.

  2008cites this paper
• A study of microglial metabotropic glutamate receptor modulation of inflammation

  2007cites this paper
• The Use of Knock-Out Mice Unravels Distinct Roles for mGlu2 and mGlu3 Metabotropic Glutamate Receptors in Mechanisms of Neurodegeneration/Neuroprotection

  2007influential citation
• TheUseofKnock-OutMiceUnravelsDistinctRolesfor mGlu2andmGlu3MetabotropicGlutamateReceptorsin MechanismsofNeurodegeneration/Neuroprotection

  2007cites this paper
• Metabotropic glutamate receptors

  2007cites this paper
• Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease

  2006cites this paper
• Oxidative stress and the viability of osteoblasts and cerebellar granule neurones.

  2006cites this paper
• CHAPTER 6 – Nicotine

  2006cites this paper
• Alternative splicing of human metabotropic glutamate receptor 3

  2006cites this paper
• Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo.

  2005cites this paper
• Seizures induced in immature rats by homocysteic acid and the associated brain damage are prevented by group II metabotropic glutamate receptor agonist (2R,4R)-4-aminopyrrolidine-2,4-dicarboxylate.

  2005cites this paper
• Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo 1

  2005influential citation
• Activation of metabotropic glutamate receptor 3 enhances interleukin (IL)-1beta-stimulated release of IL-6 in cultured human astrocytes.

  2005cites this paper
• PERFIL ONTOGENÉTICO DA CAPTAÇÃO BASAL DE GLUTAMATO EM FATIAS DE ESTRUTURAS CEREBRAIS DE RATOS E AVALIAÇÃO DE SUA SENSIBILIDADE À GUANOSINA

  2004cites this paper
• 2R,4R-APDC influence on hypoxia-induced impairment of learning and memory processes in passive avoidance test.

  2004cites this paper
• Partial involvement of group I metabotropic glutamate receptors in the neurotoxicity of 3-N-oxalyl-L-2,3-diaminopropanoic acid (L-beta-ODAP).

  2004cites this paper
• Chapter 10 Excitotoxicity and Oxidative Stress in Pathogenesis of Amyotrophic Lateral Sclerosis/Motor Neuron Disease

  2003cites this paper
• GluR2 knockdown reveals a dissociation between [Ca2+]i surge and neurotoxicity.

  2003cites this paper
• NONLINEAR EFFECTS OF GLUTAMATE AND KCl ON GLUTAMATE TOXICITY IN CULTURED RAT CEREBELLAR NEURONS

  2003cites this paper
• Neuroprotective activity of metabotropic glutamate receptor ligands.

  2002cites this paper
• Neuroprotective effects of N-acetylaspartylglutamate in a neonatal rat model of hypoxia-ischemia.

  2002cites this paper
• The pharmacological manipulation of glutamate receptors and neuroprotection.

  2002cites this paper
• Comparative analysis of group II metabotropic glutamate receptor immunoreactivity in Brodmann's area 46 of the dorsolateral prefrontal cortex from patients with schizophrenia and normal subjects

  2002cites this paper
• Molecular and Cellular Biology of Neuroprotection in the CNS

  2002cites this paper
• Excitatory amino acid neurotoxicity.

  2002cites this paper
• Role of group II and group III metabotropic glutamate receptors in spinal cord injury.

  2002cites this paper
• A possible role for glutamate receptor-mediated excitotoxicity in chronic pain

  2001cites this paper
• Increased Seizure Susceptibility in Mice Lacking Metabotropic Glutamate Receptor 7

  2001cites this paper
• Metabotropic Glutamate Receptor Subtypes as Targets for Neuroprotective Drugs

  2001cites this paper
• Group II metabotropic glutamate receptor activation protects striatal dopaminergic nerve terminals against MPP+‐induced neurotoxicity along with brain‐derived neurotrophic factor induction

  2001influential citation
• The mGlu(2/3) agonist 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate, is anti- and proconvulsant in DBA/2 mice.

  2001cites this paper
• Group II mGlu receptor agonists fail to protect against various neurotoxic insults induced in murine cortical, striatal and cerebellar granular pure neuronal cultures.

  2001cites this paper
• Traumatic brain injury: developmental differences in glutamate receptor response and the impact on treatment.

  2001cites this paper
• Excitatory amino acids and neurodegeneration: a hypothetical role of calcium precipitation

  2000cites this paper
• Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal.

  2000cites this paper
• Neuroprotection by metabotropic glutamate receptor glutamate receptor agonists: LY354740, LY379268 and LY389795.

  1999cites this paper
• Neuroprotective Actions of Novel and Potent Ligands of Group I and Group II Metabotropic Glutamate Receptors

  1999cites this paper
• Metabotropic G-protein-coupled glutamate receptors as therapeutic targets.

  1999cites this paper